Use and Misuse of Preoperative Cardiac Testing for Noncardiac Surgery

  • H.-J. Priebe
Conference paper


Perioperative cardiac morbidity and mortality are of substantial medical and economic concern. Thus, the primary goal of effective perioperative management is to implement strategies that reliably improve outcome. It is the (as yet unproven) premise that preoperative risk stratification based on the results of preoperative cardiac testing is one of such measures that will improve cardiac outcome, due to the modifying effects it can have on overall perioperative management.


Percutaneous Coronary Intervention Coronary Revascularization Noncardiac Surgery Major Vascular Surgery Metabolic Equivalent Task 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Grayburn PA, Hillis LD (2003) Cardiac events in patients undergoing noncardiac surgery: shifting the paradigm from noninvasive risk stratification to therapy. Ann Intern Med 138:506–511PubMedGoogle Scholar
  2. 2.
    Ridley S (2003) Cardiac scoring systems — what is their value? Anaesthesia 58:985–991PubMedCrossRefGoogle Scholar
  3. 3.
    Chassot PG, Delabays A, Spahn DR (2002) Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. Br J Anaesth 89:747–759PubMedCrossRefGoogle Scholar
  4. 4.
    Fagan TJ (1975) Nomogram for Bayes’ theorem. N Engl J Med 293:257PubMedGoogle Scholar
  5. 5.
    Eagle KA, Berger PB, Calkins H et al (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery — Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105:1257–1267PubMedGoogle Scholar
  6. 6.
    Falcone RA, Nass C, Jermyn R et al (2003) The value of preoperative pharmacologic stress testing before vascular surgery using ACC/AHA guidelines: a prospective, randomized trial. J Cardiothorac Vasc Anesth 17:694–698PubMedCrossRefGoogle Scholar
  7. 7.
    Mason JJ, Owens DK, Harris RA et al (1995) The role of coronary angiography and coronary revascularization before noncardiac surgery. JAMA 273:1919–1925PubMedCrossRefGoogle Scholar
  8. 8.
    McFalls EO, Ward HB, Moritz TE et al (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351:2795–2804PubMedCrossRefGoogle Scholar
  9. 9.
    Spahn DR, Howell SJ, Delabays A et al (2006) Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth 96:675–677PubMedCrossRefGoogle Scholar
  10. 10.
    Kertai MD, Bogar L, Gal J, Poldermans D (2006) Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients? Acta Anaesthesiol Scand 50:816–827PubMedCrossRefGoogle Scholar
  11. 11.
    Vicenzi MN, Meislitzer B, Heitzinger B et al (2006) Coronary artery stenting and non-cardiac surgery — a prospective outcome study. Br J Anaesth 96:686–693PubMedCrossRefGoogle Scholar
  12. 12.
    De Souza DG, Baum VC, Ballert NM (2007) Late thrombosis of a drug-eluting stent presenting in the perioperative period. Anesthesiology 106:1057–1059PubMedCrossRefGoogle Scholar
  13. 13.
    Poldermans D, Shouten O, Vidakovic R et al (2007) A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery. The DECREASE-V pilot study. J Am Coll Cardiol 49:1763–1769PubMedCrossRefGoogle Scholar
  14. 14.
    Hoeks SE, Bax JJ, Poldermans D (2007) Indications of prophylactic coronary revascularization in patients undergoing major vascular surgery: the saga continues. Eur Heart J 28:519–521PubMedCrossRefGoogle Scholar
  15. 15.
    Kersten JR, Fleisher LA (2007) Drug-eluting coronary stents. What are the risks? Anesthesiology 106:898–900PubMedCrossRefGoogle Scholar
  16. 16.
    Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al (2006) ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47:216–235PubMedCrossRefGoogle Scholar
  17. 17.
    Fox K, Garcia MAA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27:1341–1381PubMedCrossRefGoogle Scholar
  18. 18.
    Palda VA, Detsky AS, American College of Physicians (1997) Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. Clinical Guideline, Part I. Ann Intern Med 127:309–312Google Scholar
  19. 19.
    Palda VA, Detsky AS (1997) Perioperative assessment and management of risk from coronary artery disease. Clinical Guideline, Part II. Ann Intern Med 127:313–328Google Scholar
  20. 20.
    Priebe H-J (2005) Perioperative myocardial infarction — aetiology and prevention. Br J Anaesth 95:3–9PubMedCrossRefGoogle Scholar
  21. 21.
    Kertai MD, Bogar L, Poldermans D (2006) Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients? Acta Anaesthesiol Scand 50:816–827PubMedCrossRefGoogle Scholar
  22. 22.
    Cohn SL, Goldman L (2003) Preoperative risk evaluation and perioperative management of patients with coronary artery disease. Med Clin N Am 87:111–136PubMedCrossRefGoogle Scholar
  23. 23.
    Mukherjee D, Eagle KA (2003) Perioperative cardiac assessment for noncardiac surgery: eight steps to the best possible outcome. Circulation 107:2771–2774PubMedCrossRefGoogle Scholar
  24. 24.
    Henke PK, Blackburn S, Proctor MC et al (2004) Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are under-prescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39:357–365PubMedCrossRefGoogle Scholar
  25. 25.
    Wesorick DH, Eagle KA (2005) The preoperative cardiovascular evaluation of the intermediate-risk patient: new data, changing strategies. Am J Med 118:1413.e1–9CrossRefGoogle Scholar
  26. 26.
    Poldermans D, Bax JJ, Schouten O et al (2006) Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving betablocker therapy with tight heart rate control? J Am Coll Cardiol 48:984–989CrossRefGoogle Scholar
  27. 27.
    Eagle KA, Lau WC (2006) Any need for preoperative cardiac testingin intermediate-risk patients with tight beta-adrenergic blockade? J Am Coll Cardiol 48:970–972PubMedCrossRefGoogle Scholar
  28. 28.
    Auerbach A, Goldman L (2006) Assessing and reducing cardiac risk of noncardiac surgery. Circulation 113:1361–1376PubMedCrossRefGoogle Scholar
  29. 29.
    Durazzo AES, Machado FS, Ikeoka DT et al (2004) Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39:967–976PubMedCrossRefGoogle Scholar
  30. 30.
    Kennedy J, Quan H, Buchan AM et al (2005) Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36:2072–2076PubMedCrossRefGoogle Scholar
  31. 31.
    McGirt MJ, Perler BA, Brooke BS et al (2005) 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42:829–836PubMedCrossRefGoogle Scholar
  32. 32.
    O’Neil-Callahan K, Katsimaglis G, Tepper MR et al (2005) Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. J Am Coll Cardiol 45:336–342PubMedCrossRefGoogle Scholar
  33. 33.
    Shouten O, Kertai MD, Bax JJ et al (2005) Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 95:658–660CrossRefGoogle Scholar
  34. 34.
    Ward RP, Leeper NJ, Kirkpatrick JN et al (2005) The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 104:264–268PubMedCrossRefGoogle Scholar
  35. 35.
    Boushra NN, Muntazar M (2006) Review article: the role of statins in reducing perioperative cardiac risk: physiologic and clinical perspectives. Can J Anesth 53:1126–1147PubMedCrossRefGoogle Scholar
  36. 36.
    Kapoor AS, Kanji H, Buckingham J et al (2006) Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 333:1149PubMedCrossRefGoogle Scholar
  37. 37.
    Hindler K, Shaw A, Samuels J et al (2006) Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 105:1260–1272PubMedCrossRefGoogle Scholar
  38. 38.
    Kersten JR, Fleisher LA (2006) Statins. The next advance in cardioprotection? Anesthesiology 105:1079–1080PubMedCrossRefGoogle Scholar
  39. 39.
    Mangano DT, for the Multicenter Study of Perioperative Ischemia Research Group (2002) Aspirin and mortality from coronary bypass surgery. N Engl J Med 347:1309–1317Google Scholar
  40. 40.
    Boersma E, Poldermans D, Bax JJ et al, for the DECREASE Study Group (2001) Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 285:1865–1873Google Scholar
  41. 41.
    London MJ, Zaugg M, Schaub MC et al (2004) Perioperative ß-adrenergic receptor blockade. Physiologic foundations and clinical controversies. Anesthesiology 100:170–175PubMedCrossRefGoogle Scholar
  42. 42.
    Lindenauer PK, Pekow P, Wang K et al (2005) Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353:349–361PubMedCrossRefGoogle Scholar
  43. 43.
    Van de Pol MA, Van Houdenhoven M, Hans EW et al (2006) Influence of cardiac risk factors and medication on length of hospitalization in patients undergoing major vascular surgery. Am J Cardiol 97:1423–1426PubMedCrossRefGoogle Scholar
  44. 44.
    Boden WE, O’Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503–1516PubMedCrossRefGoogle Scholar
  45. 45.
    Nishina K, Mikawa K, Uesugi T et al (2002) Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology 96:323–329PubMedCrossRefGoogle Scholar
  46. 46.
    Wallace AW, Galindez D, Salahieh A et al (2004) Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 101:284–293PubMedCrossRefGoogle Scholar
  47. 47.
    Wijeysundera DN, Naik JS, Beattie S (2003) Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 114:742–752PubMedCrossRefGoogle Scholar
  48. 48.
    Legner VJ, Doerner D, McCormick WC et al (2006) Clinician agreement with perioperative cardiovascular evaluation guidelines and clinical outcomes. Am J Cardiol 97:118–122PubMedCrossRefGoogle Scholar
  49. 49.
    Auerbach DA, Goldman L (2002) β-Blockers and reduction of cardiac events in noncardiac surgery. Scientific review. JAMA 287:1435–1444PubMedCrossRefGoogle Scholar
  50. 50.
    Cohn SL, Goldman L (2003) Preoperative risk evaluation and perioperative management of patients with coronary artery disease. Med Clin N Am 87:111–136PubMedCrossRefGoogle Scholar
  51. 51.
    Feringa HHH, Bax JJ, Boersma E et al (2006) High-dose ß-blockers and tight heart rate control reduce myocardial ischemia and troponin release in vascular surgery patients. Circulation 114[suppl 1]: I–344–349Google Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • H.-J. Priebe
    • 1
  1. 1.Department of AnaesthesiaUniversity HospitalFreiburgGermany

Personalised recommendations